Skip to main content
Springer Nature Link
Account
  • 20kAccesses
  • 210Citations
  • 26Altmetric
  • 1Mention

Metrics

Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial

Last updated: Wed, 22 Jul 2026 18:00:37 UTC

Accesses

Accesses is an approximate count of unique views and downloads. This number can fluctuate depending on multiple factors.

We update counts daily.

20k Accesses

Citations

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.

210Citations

Altmetric

Altmetric score 26
  • 21 tweeters
  • 1 news outlets
  • 1 Video uploaders
  • 300 Mendeley

Altmetric calculates a score based on the online attention an article gets — the higher the score, the more online attention an article has received.

The donut visual summarises attention from different sources such as social media and news outlets. A breakdown is shown in the legend.

Older articles have had more time to get noticed, so Altmetric provides context data for articles of a similar age.

This article is in the 92nd percentile (ranked 33,597th) of the 472,426 tracked articles of a similar age in all journals and the 94th percentile (ranked 1st) of the 17 tracked articles of a similar age in Nutrition & Metabolism.

View more on Altmetric.

Mentions

This list highlights individual mainstream news articles and blogs that cite the article.

Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media.

Altmetric are responsible for the curation of this list and provide updates hourly.

Back to article page